EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
SHORT INTEREST
5.18M 09/30/19
P/E Current
-1.93
P/E Ratio (with extraordinary items)
-2.86
Average Recommendation: BUY
Average Target Price: 5.13
SHORT INTEREST
5.18M 09/30/19
P/E Current
-1.93
P/E Ratio (with extraordinary items)
-2.86
Average Recommendation: BUY
Average Target Price: 5.13
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media